InsiderClue
Stocks · Health care · Services-Medical Laboratories

BIODESIX INC

BDSX Clue Score48
United States Fiscal year ends December CIK 0001439725
$26.02 +1.52% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $26.02 +250.67% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 28 Oct 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue24.6Operating income−26.7Net income−30.7Fiscal year 2020Revenue45.6 +85.6%Operating income−22.9Net income−65.4Fiscal year 2021Revenue54.5 +19.6%Operating income−40.9Net income−43.2EPS, diluted−1.58Fiscal year 2022Revenue38.2 −29.9%Operating income−50.6Net income−65.4EPS, diluted−1.55Fiscal year 2023Revenue49.1 +28.5%Operating income−41.3Net income−52.1EPS, diluted−0.64Fiscal year 2024Revenue71.3 +45.3%Operating income−34.5Net income−42.9EPS, diluted−6.64Fiscal year 2025Revenue88.5 +24.1%Operating income−27.9Net income−35.3EPS, diluted−4.67
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 24.6 45.6 54.5 38.2 49.1 71.3 88.5
Growth +85.6% +19.6% −29.9% +28.5% +45.3% +24.1%
Operating income −26.7 −22.9 −40.9 −50.6 −41.3 −34.5 −27.9
Net income −30.7 −65.4 −43.2 −65.4 −52.1 −42.9 −35.3
Growth
EPS, diluted n/a n/a −1.58 −1.55 −0.64 −6.64 −4.67

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−108.9%Net margin−125.1%Free cash flow margin−93.8%Fiscal year 2020Operating margin−50.3%Net margin−143.7%Free cash flow margin−51.2%Fiscal year 2021Operating margin−75.1%Net margin−79.2%Free cash flow margin−55.9%Fiscal year 2022Operating margin−132.4%Net margin−171.3%Free cash flow margin−126.3%Fiscal year 2023Operating margin−84.2%Net margin−106.2%Free cash flow margin−93.3%Fiscal year 2024Operating margin−48.4%Net margin−60.2%Free cash flow margin−72.7%Fiscal year 2025Operating margin−31.5%Net margin−39.8%Free cash flow margin−26.6%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −108.9% −50.3% −75.1% −132.4% −84.2% −48.4% −31.5%
Net margin −125.1% −143.7% −79.2% −171.3% −106.2% −60.2% −39.8%
Free cash flow margin −93.8% −51.2% −55.9% −126.3% −93.3% −72.7% −26.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−21.7Capital expenditure−1.3Free cash flow−23.0Fiscal year 2020Operating cash flow−21.4Capital expenditure−1.9Free cash flow−23.3Fiscal year 2021Operating cash flow−28.2Capital expenditure−2.2Free cash flow−30.5Fiscal year 2022Operating cash flow−45.0Capital expenditure−3.3Free cash flow−48.3Fiscal year 2023Operating cash flow−22.9Capital expenditure−22.9Free cash flow−45.8Fiscal year 2024Operating cash flow−48.6Capital expenditure−3.2Free cash flow−51.9Fiscal year 2025Operating cash flow−23.3Capital expenditure−0.3Free cash flow−23.5
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −21.7 −21.4 −28.2 −45.0 −22.9 −48.6 −23.3
Capital expenditure −1.3 −1.9 −2.2 −3.3 −22.9 −3.2 −0.3
Free cash flow −23.0 −23.3 −30.5 −48.3 −45.8 −51.9 −23.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash5.3Shareholders’ equity−225.1Fiscal year 2020Cash62.1Total debt28.1Net cash (debt)34.0Shareholders’ equity41.2Debt to equity0.68Fiscal year 2021Cash32.7Total debt10.1Net cash (debt)22.6Shareholders’ equity19.7Debt to equity0.51Fiscal year 2022Cash43.1Total debt30.1Net cash (debt)13.0Shareholders’ equity20.6Debt to equity1.46Fiscal year 2023Cash26.3Total debt40.1Net cash (debt)−13.8Shareholders’ equity4.6Debt to equity8.75Fiscal year 2024Cash26.2Total debt40.0Net cash (debt)−13.8Shareholders’ equity20.9Debt to equity1.92Fiscal year 2025Cash19.0Total debt50.0Net cash (debt)−31.0Shareholders’ equity−2.5
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 5.3 62.1 32.7 43.1 26.3 26.2 19.0
Total debt n/a 28.1 10.1 30.1 40.1 40.0 50.0
Net cash (debt) n/a 34.0 22.6 13.0 −13.8 −13.8 −31.0
Shareholders’ equity −225.1 41.2 19.7 20.6 4.6 20.9 −2.5
Debt to equity n/a 0.68 0.51 1.46 8.75 1.92 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
24.6 45.6 54.5 38.2 49.1 71.3 88.5
Growth +85.6% +19.6% −29.9% +28.5% +45.3% +24.1%
10.5 10.8 12.8 13.1 10.0 9.6 12.0
30.6 34.9 50.5 61.5 67.4 80.5 87.5
−26.7 −22.9 −40.9 −50.6 −41.3 −34.5 −27.9
Growth
n/a 0.0 0.0 0.0 0.0 0.0 0.0
−30.7 −65.4 −43.2 −65.4 −52.1 −42.9 −35.3
Growth
Per share
n/a n/a −1.58 −1.55 −0.64 −6.64 −4.67
n/a n/a −1.58 −1.55 −0.64 −6.64 −4.67
Growth
n/a n/a 27.4 42.1 82.1 6.5 7.6
n/a n/a 27.4 42.1 82.1 6.5 7.6
Growth +53.9% +95.0% −92.1% +16.7%

† The diluted share count jumps at 2022 and 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 14.2% a year over five years.
  • Operating margin is up 18.8 points on five years ago, at -31.5%.
  • A net loss in 7 of 7 years on file.